PapersFlow Research Brief
Antimicrobial Peptides and Activities
Research Guide
What is Antimicrobial Peptides and Activities?
Antimicrobial peptides are small molecules produced by multicellular organisms that contribute to host defense through direct microbicidal activity, immune modulation, and disruption of microbial membranes.
The field encompasses 55,620 papers on antimicrobial peptides, focusing on their structure, mechanisms of action, and roles in innate immunity. Key studies examine whether these peptides act as pore formers or metabolic inhibitors in bacteria, as shown in 'Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?' by Brogden (2005). Methods for evaluating their activity, such as agar and broth dilution for minimal inhibitory concentration, are detailed in standard protocols.
Topic Hierarchy
Research Sub-Topics
Antimicrobial Peptide Mechanisms of Action
This sub-topic investigates membrane disruption, intracellular targeting, and immunomodulatory mechanisms of cationic antimicrobial peptides against bacteria and fungi. Researchers use biophysical assays and structural biology to elucidate pore formation and metabolic inhibition.
Antimicrobial Peptides in Innate Immunity
This sub-topic examines the role of host-derived antimicrobial peptides in mucosal and skin immunity, including expression regulation via Toll-like receptors. Researchers study deficiency states and evolutionary conservation in host defense.
Structure-Activity Relationships of Antimicrobial Peptides
This sub-topic focuses on sequence, conformation, and chemical modifications optimizing antimicrobial activity and selectivity. Researchers apply NMR, crystallography, and machine learning for peptide engineering.
Antimicrobial Peptides Against Resistance
This sub-topic explores peptides combating multidrug-resistant pathogens like MRSA and Gram-negative bacteria, including synergy with conventional antibiotics. Researchers assess resistance evolution and clinical isolates.
Therapeutic Applications of Antimicrobial Peptides
This sub-topic covers preclinical and clinical translation of antimicrobial peptides for wound healing, sepsis, and cancer adjunct therapy. Researchers evaluate pharmacokinetics, toxicity, and delivery systems like nanoparticles.
Why It Matters
Antimicrobial peptides address antimicrobial resistance by offering alternatives to conventional antibiotics, with potential as therapeutic agents in host defense and innate immunity. 'Antimicrobial peptides of multicellular organisms' by Zasloff (2002) with 8257 citations highlights their natural production in organisms for combating infections. In vitro evaluation methods from 'Methods for in vitro evaluating antimicrobial activity: A review' by Balouiri et al. (2015) with 6569 citations enable testing of peptide efficacy against resistant microbes, supporting development in peptide antibiotics. 'Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances' by Wiegand et al. (2008) with 5810 citations provides protocols used in labs worldwide to quantify activity, aiding clinical translation.
Reading Guide
Where to Start
'Antimicrobial peptides of multicellular organisms' by Zasloff (2002) is the starting point because it provides a foundational overview of their discovery, roles in host defense, and therapeutic promise, serving as the most cited paper with 8257 citations.
Key Papers Explained
'Antimicrobial peptides of multicellular organisms' by Zasloff (2002) introduces core concepts, which Brogden (2005) in 'Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?' builds on by debating mechanisms. Balouiri et al. (2015) in 'Methods for in vitro evaluating antimicrobial activity: A review' and Wiegand et al. (2008) in 'Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances' provide evaluation tools. Akira et al. (2001) in 'Toll-like receptors: critical proteins linking innate and acquired immunity' connects peptides to immunity signaling.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current frontiers emphasize therapeutic development against resistance, drawing from mechanisms in Brogden (2005) and evaluation methods in Balouiri et al. (2015). No recent preprints or news available, so focus remains on refining peptide antibiotics and innate immunity integration from foundational works like Zasloff (2002).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Antimicrobial peptides of multicellular organisms | 2002 | Nature | 8.3K | ✕ |
| 2 | Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Muta... | 1998 | Science | 7.5K | ✕ |
| 3 | Methods for in vitro evaluating antimicrobial activity: A review | 2015 | Journal of Pharmaceuti... | 6.6K | ✓ |
| 4 | Toll-Like Receptors | 2003 | Annual Review of Immun... | 6.1K | ✕ |
| 5 | Agar and broth dilution methods to determine the minimal inhib... | 2008 | Nature Protocols | 5.8K | ✕ |
| 6 | Antimicrobial peptides: pore formers or metabolic inhibitors i... | 2005 | Nature Reviews Microbi... | 5.6K | ✕ |
| 7 | Exosomes: composition, biogenesis and function | 2002 | Nature reviews. Immuno... | 5.3K | ✕ |
| 8 | Toll-like receptors: critical proteins linking innate and acqu... | 2001 | Nature Immunology | 4.7K | ✕ |
| 9 | SignalP 5.0 improves signal peptide predictions using deep neu... | 2019 | Nature Biotechnology | 4.4K | ✓ |
| 10 | Toll-like receptors and innate immunity | 2001 | Nature reviews. Immuno... | 4.2K | ✕ |
Frequently Asked Questions
What are antimicrobial peptides?
Antimicrobial peptides are molecules from multicellular organisms involved in host defense and innate immunity. 'Antimicrobial peptides of multicellular organisms' by Zasloff (2002) describes their production and microbicidal roles. They exhibit cationic properties enabling membrane disruption.
How are antimicrobial activities evaluated in vitro?
Agar and broth dilution methods determine the minimal inhibitory concentration (MIC) of antimicrobial substances. 'Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances' by Wiegand et al. (2008) outlines these protocols. 'Methods for in vitro evaluating antimicrobial activity: A review' by Balouiri et al. (2015) reviews various techniques for activity assessment.
What mechanisms do antimicrobial peptides use against bacteria?
Antimicrobial peptides may function as pore formers or metabolic inhibitors in bacteria. 'Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?' by Brogden (2005) explores these modes of action. Their cationic nature facilitates interaction with microbial membranes.
What role do Toll-like receptors play with antimicrobial peptides?
Toll-like receptors link innate and acquired immunity, sensing microbial invasion that antimicrobial peptides help counter. 'Toll-like receptors: critical proteins linking innate and acquired immunity' by Akira et al. (2001) details this integration. They initiate host defense overlapping with peptide activities.
How do mutations affect LPS signaling related to antimicrobial defense?
Mutations in the Tlr4 gene impair LPS signaling, increasing susceptibility to Gram-negative infections despite resistance to endotoxin. 'Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene' by Poltorak et al. (1998) identifies these effects. This relates to broader innate immunity involving antimicrobial peptides.
What is the current state of antimicrobial peptide research?
Research includes 55,620 works on mechanisms, resistance challenges, and therapeutic potential. Papers like 'Antimicrobial peptides of multicellular organisms' by Zasloff (2002) remain highly cited at 8257 times. Focus persists on peptide-based agents amid resistance issues.
Open Research Questions
- ? Do antimicrobial peptides primarily disrupt bacterial membranes or inhibit metabolic processes?
- ? How can antimicrobial peptides overcome resistance mechanisms in clinical pathogens?
- ? What structural modifications enhance the stability and efficacy of therapeutic antimicrobial peptides?
- ? How do antimicrobial peptides interact with Toll-like receptor signaling in innate immunity?
- ? Which delivery methods improve the bioavailability of antimicrobial peptides in vivo?
Recent Trends
The field holds steady at 55,620 papers with no specified 5-year growth rate.
Highly cited works like 'Antimicrobial peptides of multicellular organisms' by Zasloff (2002, 8257 citations) and 'Methods for in vitro evaluating antimicrobial activity: A review' by Balouiri et al. (2015, 6569 citations) continue dominating.
No recent preprints or news in the last 6-12 months indicate sustained focus on established mechanisms and methods.
Research Antimicrobial Peptides and Activities with AI
PapersFlow provides specialized AI tools for Immunology and Microbiology researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Antimicrobial Peptides and Activities with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Immunology and Microbiology researchers